Using the ELF test, FIB-4 and NAFLD fibrosis score to screen the population for liver disease
-
Published:2023-08
Issue:2
Volume:79
Page:277-286
-
ISSN:0168-8278
-
Container-title:Journal of Hepatology
-
language:en
-
Short-container-title:Journal of Hepatology
Author:
Kjaergaard MariaORCID, Lindvig Katrine Prier, Thorhauge Katrine HoltzORCID, Andersen Peter, Hansen Johanne KraghORCID, Kastrup NannaORCID, Jensen Jane Møller, Hansen Camilla DalbyORCID, Johansen StineORCID, Israelsen Mads, Torp Nikolaj, Trelle Morten BeckORCID, Shan Shan, Detlefsen Sönke, Antonsen Steen, Andersen Jørgen Ellegaard, Graupera Isabel, Ginés PereORCID, Thiele MajaORCID, Krag AleksanderORCID
Reference31 articles.
1. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019;Vos;Lancet,2020 2. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015;Lancet,2016 3. The EASL Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality;Karlsen;The Lancet,2022 4. Population screening for liver fibrosis: toward early diagnosis and intervention for chronic liver diseases;Gines;Hepatology,2022 5. Liver fibrosis, but No other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease;Angulo;Gastroenterology,2015
Cited by
55 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|